Cargando…
Agomelatine as monotherapy for major depression: an outpatient, open-label study
BACKGROUND: Agomelatine is a novel antidepressant agonist to MT1 and MT2 subtypes of melatoninergic receptors (MT1 and MT2) and antagonist to 5-HT(2C) subtype of serotonergic (5-HT(2C)) receptors, which has shown antidepressant efficacy in short-term and long-term trials as well as in clinical pract...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808155/ https://www.ncbi.nlm.nih.gov/pubmed/24174876 http://dx.doi.org/10.2147/NDT.S49062 |